Diabetes

ARTICLES

The earliest studies involving diabetes therapy for Alzheimer’s are recruiting patients.
Dennis P. Scanlon, PhD; Zachary T. Bloomgarden, MD, MACE; Robert Gabbay, MD, PhD, FACP; Michael Gardner, MD; and John A. Johnson, MD, MBA, discuss the results of key trials and their important implications for the prevention of complications of diabetes, such as cardiovascular events; highlight challenges with adherence among the diabetic population; and suggest strategies for collaboration among all stakeholders involved in patient care to help patients properly manage their disease and reduce the risk of adverse events.
In this first segment of the American Journal of Managed Care Peer Exchange, “Reducing Cardiovascular Mortality in Patients with Type 2 Diabetes Mellitus,” program moderator Dennis P. Scanlon, PhD, introduces expert panelists Zachary T. Bloomgarden, MD, MACE; Robert Gabbay, MD, PhD, FACP; Michael Gardner, MD; and John A. Johnson, MD, MBA. The panelists discuss the incidence and prevalence of diabetes and how to better address prediabetes.
As primary care physicians and leaders of Wellframe—a mobile health company working with payers and physicians groups to extend care between visits for patients with complex comorbidities—Drs Panch and Goodman discuss their experiences building a mobile application used by elderly patients to communicate with clinicians and manage chronic disease.
The collaboration is the latest in a series of partnerships for diabetes care announced by the medical device maker.

EVENTS

April 12th, 2014
Hershey, PA
May 22nd to 25th , 2014
Fort Lauderdale, FL
August 14th to 16th, 2014
Stowe, VT
Compendia
Diabetes Compendium
Oncology Compendium
Reimbursement Compendium
HF Compendium
$AD300x250BB$
$vacMongoViewPlus$